Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F5VGE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,028
Award facts
- Contract value 100% obligated
- $24,027.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,027.82 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on January 16, 2026, with an ultimate completion date of January 20, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery order falls under AmerisourceBergen's parent company Cencora, Inc.'s significantly larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031.
This delivery order exemplifies the ongoing pharmaceutical supply operations under Cencora's comprehensive IDC, which supports military healthcare programs globally with an extensive range of medications, medical devices, vaccines, and specialized healthcare commodities. RINVOQ ER (upadacitinib extended-release) is a Janus kinase inhibitor used in treating inflammatory conditions. The contract structure enables DLA to efficiently procure essential pharmaceutical products across multiple therapeutic domains while leveraging a qualified vendor capable of meeting federal medical supply requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26F5VGE?
SPE2DR26F5VGE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F5VGE worth?
The government has obligated $24,028 on SPE2DR26F5VGE.
Is contract SPE2DR26F5VGE an order under another contract?
Yes. SPE2DR26F5VGE is a delivery order under SPE2DR25D2105, an indefinite delivery contract.
Was contract SPE2DR26F5VGE competed?
The extent of competition for SPE2DR26F5VGE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award